Jazz Pharms Inc Drug Patent Portfolio

Jazz Pharms Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Jazz Pharms Inc News

How Major Pharmaceutical Companies Aim to Undermine the Cannabis Sector as We Know It

13 Nov, 2025

Potential Reactions from Investors Following Jazz Pharmaceuticals' Global Settlement on LUMRYZ

01 Nov, 2025

Jazz Unable to Dismiss Avadel's Antitrust Allegations in Sleep Medication Dispute - Bloomberg Law News

16 Sep, 2025

Uncommon Conditions Achieve Four FDA Milestones in August - BioSpace

02 Sep, 2025

See More